nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2C8—Simvastatin—atherosclerosis	0.0968	0.128	CbGbCtD
Sulfadiazine—CYP2C8—Pravastatin—atherosclerosis	0.0947	0.125	CbGbCtD
Sulfadiazine—CYP2C8—Lovastatin—atherosclerosis	0.0947	0.125	CbGbCtD
Sulfadiazine—CYP2C9—Rosuvastatin—atherosclerosis	0.0726	0.0957	CbGbCtD
Sulfadiazine—CYP2C9—Simvastatin—atherosclerosis	0.0675	0.0889	CbGbCtD
Sulfadiazine—CYP2C9—Lovastatin—atherosclerosis	0.0661	0.087	CbGbCtD
Sulfadiazine—CYP2C9—Pravastatin—atherosclerosis	0.0661	0.087	CbGbCtD
Sulfadiazine—CYP3A4—Ezetimibe—atherosclerosis	0.0422	0.0556	CbGbCtD
Sulfadiazine—CYP3A4—Rosuvastatin—atherosclerosis	0.0422	0.0556	CbGbCtD
Sulfadiazine—CYP3A4—Simvastatin—atherosclerosis	0.0393	0.0517	CbGbCtD
Sulfadiazine—CYP3A4—Lovastatin—atherosclerosis	0.0384	0.0506	CbGbCtD
Sulfadiazine—CYP3A4—Pravastatin—atherosclerosis	0.0384	0.0506	CbGbCtD
Sulfadiazine—Lupus erythematosus—Lovastatin—atherosclerosis	0.00678	0.0336	CcSEcCtD
Sulfadiazine—Lupus erythematosus—Simvastatin—atherosclerosis	0.00634	0.0314	CcSEcCtD
Sulfadiazine—Lupus erythematosus—Pravastatin—atherosclerosis	0.00573	0.0284	CcSEcCtD
Sulfadiazine—Systemic lupus erythematosus—Lovastatin—atherosclerosis	0.00456	0.0226	CcSEcCtD
Sulfadiazine—Hepatic necrosis—Lovastatin—atherosclerosis	0.00434	0.0215	CcSEcCtD
Sulfadiazine—Systemic lupus erythematosus—Simvastatin—atherosclerosis	0.00427	0.0211	CcSEcCtD
Sulfadiazine—Hepatic necrosis—Simvastatin—atherosclerosis	0.00406	0.0201	CcSEcCtD
Sulfadiazine—Systemic lupus erythematosus—Pravastatin—atherosclerosis	0.00386	0.0191	CcSEcCtD
Sulfadiazine—Hepatic necrosis—Pravastatin—atherosclerosis	0.00367	0.0182	CcSEcCtD
Sulfadiazine—Blood disorder—Rosuvastatin—atherosclerosis	0.00357	0.0177	CcSEcCtD
Sulfadiazine—Burning sensation—Niacin—atherosclerosis	0.00312	0.0155	CcSEcCtD
Sulfadiazine—Skin discolouration—Niacin—atherosclerosis	0.0024	0.0119	CcSEcCtD
Sulfadiazine—Sulfisoxazole—EDNRA—atherosclerosis	0.00226	0.264	CrCbGaD
Sulfadiazine—Sulfasalazine—PLA2G1B—atherosclerosis	0.00212	0.248	CrCbGaD
Sulfadiazine—Skin exfoliation—Niacin—atherosclerosis	0.00207	0.0103	CcSEcCtD
Sulfadiazine—Vascular purpura—Lovastatin—atherosclerosis	0.00205	0.0102	CcSEcCtD
Sulfadiazine—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00203	0.0101	CcSEcCtD
Sulfadiazine—Vascular purpura—Simvastatin—atherosclerosis	0.00192	0.0095	CcSEcCtD
Sulfadiazine—Purpura—Lovastatin—atherosclerosis	0.0019	0.00943	CcSEcCtD
Sulfadiazine—Haemolytic anaemia—Simvastatin—atherosclerosis	0.0019	0.00941	CcSEcCtD
Sulfadiazine—Pancreatitis—Rosuvastatin—atherosclerosis	0.00183	0.00908	CcSEcCtD
Sulfadiazine—Polyuria—Niacin—atherosclerosis	0.00179	0.00889	CcSEcCtD
Sulfadiazine—Purpura—Simvastatin—atherosclerosis	0.00178	0.00882	CcSEcCtD
Sulfadiazine—Vascular purpura—Pravastatin—atherosclerosis	0.00173	0.00859	CcSEcCtD
Sulfadiazine—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00172	0.00851	CcSEcCtD
Sulfadiazine—Depression—Rosuvastatin—atherosclerosis	0.00166	0.00824	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00165	0.00818	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00163	0.0081	CcSEcCtD
Sulfadiazine—Purpura—Pravastatin—atherosclerosis	0.00161	0.00797	CcSEcCtD
Sulfadiazine—Pancreatitis—Lovastatin—atherosclerosis	0.00155	0.0077	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00154	0.00765	CcSEcCtD
Sulfadiazine—Pancreatitis—Ezetimibe—atherosclerosis	0.00152	0.00755	CcSEcCtD
Sulfadiazine—Hepatitis—Rosuvastatin—atherosclerosis	0.0015	0.00742	CcSEcCtD
Sulfadiazine—Pancreatitis—Simvastatin—atherosclerosis	0.00145	0.0072	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.0014	0.00694	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.0014	0.00692	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00138	0.00686	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00136	0.00673	CcSEcCtD
Sulfadiazine—Depression—Simvastatin—atherosclerosis	0.00132	0.00653	CcSEcCtD
Sulfadiazine—Pancreatitis—Pravastatin—atherosclerosis	0.00131	0.00651	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00131	0.00649	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00129	0.00642	CcSEcCtD
Sulfadiazine—Hepatitis—Lovastatin—atherosclerosis	0.00127	0.00628	CcSEcCtD
Sulfadiazine—Hepatitis—Ezetimibe—atherosclerosis	0.00124	0.00616	CcSEcCtD
Sulfadiazine—Erythema multiforme—Lovastatin—atherosclerosis	0.0012	0.00594	CcSEcCtD
Sulfadiazine—Depression—Pravastatin—atherosclerosis	0.00119	0.0059	CcSEcCtD
Sulfadiazine—Hepatitis—Simvastatin—atherosclerosis	0.00119	0.00588	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00118	0.00587	CcSEcCtD
Sulfadiazine—Stomatitis—Niacin—atherosclerosis	0.00118	0.00586	CcSEcCtD
Sulfadiazine—Erythema multiforme—Ezetimibe—atherosclerosis	0.00118	0.00583	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00117	0.0058	CcSEcCtD
Sulfadiazine—Chills—Lovastatin—atherosclerosis	0.00114	0.00564	CcSEcCtD
Sulfadiazine—Sulfasalazine—ALOX5—atherosclerosis	0.00113	0.131	CrCbGaD
Sulfadiazine—Erythema multiforme—Simvastatin—atherosclerosis	0.00112	0.00556	CcSEcCtD
Sulfadiazine—Arthralgia—Rosuvastatin—atherosclerosis	0.00111	0.0055	CcSEcCtD
Sulfadiazine—Hepatitis—Niacin—atherosclerosis	0.00109	0.0054	CcSEcCtD
Sulfadiazine—Hepatitis—Pravastatin—atherosclerosis	0.00107	0.00531	CcSEcCtD
Sulfadiazine—Chills—Simvastatin—atherosclerosis	0.00106	0.00527	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00104	0.00516	CcSEcCtD
Sulfadiazine—Tinnitus—Niacin—atherosclerosis	0.00102	0.00503	CcSEcCtD
Sulfadiazine—Erythema multiforme—Pravastatin—atherosclerosis	0.00101	0.00502	CcSEcCtD
Sulfadiazine—Tinnitus—Pravastatin—atherosclerosis	0.001	0.00495	CcSEcCtD
Sulfadiazine—Vertigo—Lovastatin—atherosclerosis	0.000992	0.00492	CcSEcCtD
Sulfadiazine—Leukopenia—Lovastatin—atherosclerosis	0.000988	0.0049	CcSEcCtD
Sulfadiazine—Chills—Niacin—atherosclerosis	0.000977	0.00484	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000968	0.0048	CcSEcCtD
Sulfadiazine—Chills—Pravastatin—atherosclerosis	0.000962	0.00477	CcSEcCtD
Sulfadiazine—Insomnia—Rosuvastatin—atherosclerosis	0.000961	0.00477	CcSEcCtD
Sulfadiazine—Arthralgia—Lovastatin—atherosclerosis	0.00094	0.00466	CcSEcCtD
Sulfadiazine—Vertigo—Simvastatin—atherosclerosis	0.000927	0.0046	CcSEcCtD
Sulfadiazine—Leukopenia—Simvastatin—atherosclerosis	0.000924	0.00458	CcSEcCtD
Sulfadiazine—Arthralgia—Ezetimibe—atherosclerosis	0.000922	0.00457	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000901	0.00446	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000883	0.00438	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000882	0.00437	CcSEcCtD
Sulfadiazine—Arthralgia—Simvastatin—atherosclerosis	0.000879	0.00436	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000869	0.00431	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000865	0.00429	CcSEcCtD
Sulfadiazine—Anorexia—Lovastatin—atherosclerosis	0.000859	0.00426	CcSEcCtD
Sulfadiazine—Vertigo—Niacin—atherosclerosis	0.000852	0.00422	CcSEcCtD
Sulfadiazine—Leukopenia—Niacin—atherosclerosis	0.000848	0.00421	CcSEcCtD
Sulfadiazine—Urticaria—Rosuvastatin—atherosclerosis	0.000844	0.00419	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000843	0.00418	CcSEcCtD
Sulfadiazine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00084	0.00416	CcSEcCtD
Sulfadiazine—Vertigo—Pravastatin—atherosclerosis	0.000839	0.00416	CcSEcCtD
Sulfadiazine—Leukopenia—Pravastatin—atherosclerosis	0.000835	0.00414	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000825	0.00409	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000821	0.00407	CcSEcCtD
Sulfadiazine—Insomnia—Lovastatin—atherosclerosis	0.000815	0.00404	CcSEcCtD
Sulfadiazine—Arthralgia—Niacin—atherosclerosis	0.000807	0.004	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000805	0.00399	CcSEcCtD
Sulfadiazine—Anorexia—Simvastatin—atherosclerosis	0.000803	0.00398	CcSEcCtD
Sulfadiazine—Insomnia—Ezetimibe—atherosclerosis	0.000799	0.00396	CcSEcCtD
Sulfadiazine—Arthralgia—Pravastatin—atherosclerosis	0.000795	0.00394	CcSEcCtD
Sulfadiazine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000783	0.00388	CcSEcCtD
Sulfadiazine—Decreased appetite—Lovastatin—atherosclerosis	0.000783	0.00388	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Niacin—atherosclerosis	0.000774	0.00383	CcSEcCtD
Sulfadiazine—Decreased appetite—Ezetimibe—atherosclerosis	0.000768	0.00381	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000768	0.0038	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000763	0.00378	CcSEcCtD
Sulfadiazine—Insomnia—Simvastatin—atherosclerosis	0.000762	0.00378	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000762	0.00378	CcSEcCtD
Sulfadiazine—Pruritus—Rosuvastatin—atherosclerosis	0.000752	0.00373	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000746	0.0037	CcSEcCtD
Sulfadiazine—Anorexia—Niacin—atherosclerosis	0.000737	0.00366	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000737	0.00365	CcSEcCtD
Sulfadiazine—Decreased appetite—Simvastatin—atherosclerosis	0.000732	0.00363	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000727	0.00361	CcSEcCtD
Sulfadiazine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000727	0.0036	CcSEcCtD
Sulfadiazine—Anorexia—Pravastatin—atherosclerosis	0.000726	0.0036	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000722	0.00358	CcSEcCtD
Sulfadiazine—Urticaria—Lovastatin—atherosclerosis	0.000716	0.00355	CcSEcCtD
Sulfadiazine—Body temperature increased—Lovastatin—atherosclerosis	0.000712	0.00353	CcSEcCtD
Sulfadiazine—Abdominal pain—Lovastatin—atherosclerosis	0.000712	0.00353	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000705	0.00349	CcSEcCtD
Sulfadiazine—Urticaria—Ezetimibe—atherosclerosis	0.000702	0.00348	CcSEcCtD
Sulfadiazine—Insomnia—Niacin—atherosclerosis	0.0007	0.00347	CcSEcCtD
Sulfadiazine—Abdominal pain—Ezetimibe—atherosclerosis	0.000698	0.00346	CcSEcCtD
Sulfadiazine—Body temperature increased—Ezetimibe—atherosclerosis	0.000698	0.00346	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000694	0.00344	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000689	0.00341	CcSEcCtD
Sulfadiazine—Insomnia—Pravastatin—atherosclerosis	0.000689	0.00341	CcSEcCtD
Sulfadiazine—Decreased appetite—Niacin—atherosclerosis	0.000672	0.00333	CcSEcCtD
Sulfadiazine—Rash—Rosuvastatin—atherosclerosis	0.00067	0.00332	CcSEcCtD
Sulfadiazine—Dermatitis—Rosuvastatin—atherosclerosis	0.00067	0.00332	CcSEcCtD
Sulfadiazine—Urticaria—Simvastatin—atherosclerosis	0.000669	0.00332	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000668	0.00331	CcSEcCtD
Sulfadiazine—Abdominal pain—Simvastatin—atherosclerosis	0.000666	0.0033	CcSEcCtD
Sulfadiazine—Body temperature increased—Simvastatin—atherosclerosis	0.000666	0.0033	CcSEcCtD
Sulfadiazine—Headache—Rosuvastatin—atherosclerosis	0.000666	0.0033	CcSEcCtD
Sulfadiazine—Hypersensitivity—Lovastatin—atherosclerosis	0.000664	0.00329	CcSEcCtD
Sulfadiazine—Decreased appetite—Pravastatin—atherosclerosis	0.000662	0.00328	CcSEcCtD
Sulfadiazine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000651	0.00323	CcSEcCtD
Sulfadiazine—Sulfasalazine—PPARG—atherosclerosis	0.000644	0.0752	CrCbGaD
Sulfadiazine—Pruritus—Lovastatin—atherosclerosis	0.000637	0.00316	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Niacin—atherosclerosis	0.000633	0.00314	CcSEcCtD
Sulfadiazine—Nausea—Rosuvastatin—atherosclerosis	0.000631	0.00313	CcSEcCtD
Sulfadiazine—Pruritus—Ezetimibe—atherosclerosis	0.000625	0.0031	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000623	0.00309	CcSEcCtD
Sulfadiazine—Hypersensitivity—Simvastatin—atherosclerosis	0.000621	0.00308	CcSEcCtD
Sulfadiazine—Diarrhoea—Lovastatin—atherosclerosis	0.000616	0.00305	CcSEcCtD
Sulfadiazine—Urticaria—Niacin—atherosclerosis	0.000615	0.00305	CcSEcCtD
Sulfadiazine—Abdominal pain—Niacin—atherosclerosis	0.000612	0.00303	CcSEcCtD
Sulfadiazine—Body temperature increased—Niacin—atherosclerosis	0.000612	0.00303	CcSEcCtD
Sulfadiazine—Urticaria—Pravastatin—atherosclerosis	0.000605	0.003	CcSEcCtD
Sulfadiazine—Diarrhoea—Ezetimibe—atherosclerosis	0.000604	0.003	CcSEcCtD
Sulfadiazine—Abdominal pain—Pravastatin—atherosclerosis	0.000602	0.00298	CcSEcCtD
Sulfadiazine—Body temperature increased—Pravastatin—atherosclerosis	0.000602	0.00298	CcSEcCtD
Sulfadiazine—Pruritus—Simvastatin—atherosclerosis	0.000596	0.00295	CcSEcCtD
Sulfadiazine—Diarrhoea—Simvastatin—atherosclerosis	0.000576	0.00286	CcSEcCtD
Sulfadiazine—Vomiting—Lovastatin—atherosclerosis	0.000573	0.00284	CcSEcCtD
Sulfadiazine—Hypersensitivity—Niacin—atherosclerosis	0.00057	0.00283	CcSEcCtD
Sulfadiazine—Rash—Lovastatin—atherosclerosis	0.000568	0.00282	CcSEcCtD
Sulfadiazine—Dermatitis—Lovastatin—atherosclerosis	0.000567	0.00281	CcSEcCtD
Sulfadiazine—Headache—Lovastatin—atherosclerosis	0.000564	0.0028	CcSEcCtD
Sulfadiazine—Vomiting—Ezetimibe—atherosclerosis	0.000562	0.00278	CcSEcCtD
Sulfadiazine—Hypersensitivity—Pravastatin—atherosclerosis	0.000561	0.00278	CcSEcCtD
Sulfadiazine—Rash—Ezetimibe—atherosclerosis	0.000557	0.00276	CcSEcCtD
Sulfadiazine—Dermatitis—Ezetimibe—atherosclerosis	0.000557	0.00276	CcSEcCtD
Sulfadiazine—Headache—Ezetimibe—atherosclerosis	0.000553	0.00274	CcSEcCtD
Sulfadiazine—Pruritus—Niacin—atherosclerosis	0.000547	0.00271	CcSEcCtD
Sulfadiazine—Pruritus—Pravastatin—atherosclerosis	0.000539	0.00267	CcSEcCtD
Sulfadiazine—Vomiting—Simvastatin—atherosclerosis	0.000536	0.00266	CcSEcCtD
Sulfadiazine—Nausea—Lovastatin—atherosclerosis	0.000535	0.00265	CcSEcCtD
Sulfadiazine—Rash—Simvastatin—atherosclerosis	0.000531	0.00263	CcSEcCtD
Sulfadiazine—Dermatitis—Simvastatin—atherosclerosis	0.000531	0.00263	CcSEcCtD
Sulfadiazine—Diarrhoea—Niacin—atherosclerosis	0.000529	0.00262	CcSEcCtD
Sulfadiazine—Headache—Simvastatin—atherosclerosis	0.000528	0.00262	CcSEcCtD
Sulfadiazine—Nausea—Ezetimibe—atherosclerosis	0.000525	0.0026	CcSEcCtD
Sulfadiazine—Diarrhoea—Pravastatin—atherosclerosis	0.000521	0.00258	CcSEcCtD
Sulfadiazine—Nausea—Simvastatin—atherosclerosis	0.0005	0.00248	CcSEcCtD
Sulfadiazine—Vomiting—Niacin—atherosclerosis	0.000492	0.00244	CcSEcCtD
Sulfadiazine—Rash—Niacin—atherosclerosis	0.000488	0.00242	CcSEcCtD
Sulfadiazine—Dermatitis—Niacin—atherosclerosis	0.000487	0.00242	CcSEcCtD
Sulfadiazine—Headache—Niacin—atherosclerosis	0.000485	0.0024	CcSEcCtD
Sulfadiazine—Vomiting—Pravastatin—atherosclerosis	0.000484	0.0024	CcSEcCtD
Sulfadiazine—Rash—Pravastatin—atherosclerosis	0.00048	0.00238	CcSEcCtD
Sulfadiazine—Dermatitis—Pravastatin—atherosclerosis	0.00048	0.00238	CcSEcCtD
Sulfadiazine—Headache—Pravastatin—atherosclerosis	0.000477	0.00237	CcSEcCtD
Sulfadiazine—Sulfamethazine—ALB—atherosclerosis	0.000472	0.0551	CrCbGaD
Sulfadiazine—Dapsone—MPO—atherosclerosis	0.00047	0.0549	CrCbGaD
Sulfadiazine—Sulfamerazine—ALB—atherosclerosis	0.000461	0.0538	CrCbGaD
Sulfadiazine—Nausea—Niacin—atherosclerosis	0.00046	0.00228	CcSEcCtD
Sulfadiazine—Nausea—Pravastatin—atherosclerosis	0.000452	0.00224	CcSEcCtD
Sulfadiazine—Sulfamethizole—ALB—atherosclerosis	0.000357	0.0418	CrCbGaD
Sulfadiazine—Sulfasalazine—PTGS2—atherosclerosis	0.000272	0.0317	CrCbGaD
Sulfadiazine—Sulfamethoxazole—ALB—atherosclerosis	0.000201	0.0234	CrCbGaD
Sulfadiazine—Dapsone—PTGS2—atherosclerosis	0.000176	0.0206	CrCbGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	4.76e-05	0.00156	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	4.71e-05	0.00155	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	4.69e-05	0.00154	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	4.59e-05	0.00151	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	4.59e-05	0.00151	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	4.55e-05	0.00149	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PLTP—atherosclerosis	4.51e-05	0.00148	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	4.5e-05	0.00148	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	4.43e-05	0.00145	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	4.36e-05	0.00143	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	4.19e-05	0.00138	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LDLRAP1—atherosclerosis	4.14e-05	0.00136	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	4.09e-05	0.00134	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	4.05e-05	0.00133	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ABCG8—atherosclerosis	3.91e-05	0.00129	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LTA4H—atherosclerosis	3.91e-05	0.00129	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PLTP—atherosclerosis	3.9e-05	0.00128	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	3.88e-05	0.00127	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	3.88e-05	0.00127	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	3.88e-05	0.00127	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	3.88e-05	0.00127	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	3.83e-05	0.00126	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	3.7e-05	0.00122	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.61e-05	0.00119	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.59e-05	0.00118	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.57e-05	0.00117	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	3.55e-05	0.00117	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.48e-05	0.00115	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	3.41e-05	0.00112	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCG8—atherosclerosis	3.38e-05	0.00111	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LTA4H—atherosclerosis	3.38e-05	0.00111	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	3.37e-05	0.00111	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	3.34e-05	0.0011	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	3.3e-05	0.00108	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PLTP—atherosclerosis	3.17e-05	0.00104	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.15e-05	0.00104	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.14e-05	0.00103	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.09e-05	0.00102	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ABCG1—atherosclerosis	3.09e-05	0.00102	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.94e-05	0.000966	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.92e-05	0.00096	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LCAT—atherosclerosis	2.91e-05	0.000955	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—FABP4—atherosclerosis	2.91e-05	0.000955	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.9e-05	0.000954	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOA4—atherosclerosis	2.85e-05	0.000938	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.84e-05	0.000932	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.81e-05	0.000923	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP7A1—atherosclerosis	2.8e-05	0.000921	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCG8—atherosclerosis	2.75e-05	0.000904	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LTA4H—atherosclerosis	2.75e-05	0.000904	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.72e-05	0.000893	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCG1—atherosclerosis	2.67e-05	0.000878	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP27A1—atherosclerosis	2.59e-05	0.000851	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.56e-05	0.000843	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LCAT—atherosclerosis	2.51e-05	0.000826	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—FABP4—atherosclerosis	2.51e-05	0.000826	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOA4—atherosclerosis	2.46e-05	0.00081	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PLA2G2A—atherosclerosis	2.45e-05	0.000807	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOA2—atherosclerosis	2.45e-05	0.000807	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALOX5AP—atherosclerosis	2.45e-05	0.000807	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALOX15—atherosclerosis	2.45e-05	0.000807	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ABCG5—atherosclerosis	2.42e-05	0.000797	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP7A1—atherosclerosis	2.42e-05	0.000796	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LPA—atherosclerosis	2.34e-05	0.00077	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.31e-05	0.000759	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.29e-05	0.000751	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—BGN—atherosclerosis	2.27e-05	0.000746	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOA5—atherosclerosis	2.25e-05	0.000738	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP27A1—atherosclerosis	2.24e-05	0.000736	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.22e-05	0.000731	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.2e-05	0.000724	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCG1—atherosclerosis	2.17e-05	0.000715	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PLA2G1B—atherosclerosis	2.16e-05	0.000711	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.15e-05	0.000707	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOA2—atherosclerosis	2.12e-05	0.000698	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	2.12e-05	0.000698	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALOX15—atherosclerosis	2.12e-05	0.000698	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	2.12e-05	0.000698	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCG5—atherosclerosis	2.1e-05	0.000689	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.09e-05	0.000688	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PLTP—atherosclerosis	2.09e-05	0.000688	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALOX5—atherosclerosis	2.09e-05	0.000686	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—FABP4—atherosclerosis	2.04e-05	0.000672	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LCAT—atherosclerosis	2.04e-05	0.000672	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LPA—atherosclerosis	2.02e-05	0.000665	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOA4—atherosclerosis	2.01e-05	0.00066	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.97e-05	0.000648	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—BGN—atherosclerosis	1.96e-05	0.000645	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.95e-05	0.00064	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOA5—atherosclerosis	1.94e-05	0.000638	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.89e-05	0.00062	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.88e-05	0.000617	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NAMPT—atherosclerosis	1.87e-05	0.000615	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	1.87e-05	0.000614	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LIPC—atherosclerosis	1.86e-05	0.000612	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOC3—atherosclerosis	1.85e-05	0.000608	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.85e-05	0.000607	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LDLR—atherosclerosis	1.84e-05	0.000604	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.83e-05	0.000602	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.83e-05	0.0006	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.82e-05	0.000599	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.81e-05	0.000596	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.81e-05	0.000596	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALOX5—atherosclerosis	1.8e-05	0.000593	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CETP—atherosclerosis	1.79e-05	0.00059	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.79e-05	0.00059	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.75e-05	0.000575	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.73e-05	0.000568	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOA2—atherosclerosis	1.73e-05	0.000568	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.73e-05	0.000568	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.73e-05	0.000568	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SCARB1—atherosclerosis	1.72e-05	0.000565	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.71e-05	0.000561	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.7e-05	0.00056	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.67e-05	0.000548	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LPA—atherosclerosis	1.65e-05	0.000542	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HMGCR—atherosclerosis	1.62e-05	0.000534	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.62e-05	0.000532	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.61e-05	0.000529	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LIPC—atherosclerosis	1.61e-05	0.000529	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOC3—atherosclerosis	1.6e-05	0.000525	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—BGN—atherosclerosis	1.6e-05	0.000525	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LDLR—atherosclerosis	1.59e-05	0.000522	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.58e-05	0.000521	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOA5—atherosclerosis	1.58e-05	0.000519	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CETP—atherosclerosis	1.55e-05	0.00051	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.53e-05	0.000504	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.52e-05	0.0005	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.5e-05	0.000494	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.49e-05	0.00049	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.49e-05	0.000489	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.49e-05	0.000488	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.47e-05	0.000483	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ABCA1—atherosclerosis	1.45e-05	0.000476	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.45e-05	0.000476	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.43e-05	0.000471	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.4e-05	0.000461	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.36e-05	0.000446	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.35e-05	0.000443	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.35e-05	0.000443	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.32e-05	0.000435	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.32e-05	0.000433	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.31e-05	0.00043	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LIPC—atherosclerosis	1.31e-05	0.00043	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOC3—atherosclerosis	1.3e-05	0.000428	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.3e-05	0.000427	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LDLR—atherosclerosis	1.29e-05	0.000425	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.27e-05	0.000416	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CETP—atherosclerosis	1.26e-05	0.000415	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.25e-05	0.000411	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HMOX1—atherosclerosis	1.24e-05	0.000408	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.21e-05	0.000398	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.2e-05	0.000395	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOB—atherosclerosis	1.19e-05	0.000391	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.18e-05	0.000387	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTM1—atherosclerosis	1.16e-05	0.00038	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.14e-05	0.000375	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.14e-05	0.000374	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.14e-05	0.000374	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.14e-05	0.000374	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.14e-05	0.000374	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LPL—atherosclerosis	1.14e-05	0.000373	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.12e-05	0.00037	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GPX1—atherosclerosis	1.11e-05	0.000364	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LPA—atherosclerosis	1.09e-05	0.000357	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CD36—atherosclerosis	1.08e-05	0.000355	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HMOX1—atherosclerosis	1.07e-05	0.000353	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—BGN—atherosclerosis	1.05e-05	0.000346	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.04e-05	0.000342	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.03e-05	0.000339	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOB—atherosclerosis	1.03e-05	0.000338	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MTHFR—atherosclerosis	1.02e-05	0.000336	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.02e-05	0.000335	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPARA—atherosclerosis	1e-05	0.00033	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1e-05	0.00033	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTM1—atherosclerosis	1e-05	0.000329	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LPL—atherosclerosis	9.81e-06	0.000323	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AGT—atherosclerosis	9.71e-06	0.000319	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.68e-06	0.000318	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GPX1—atherosclerosis	9.57e-06	0.000315	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOE—atherosclerosis	9.52e-06	0.000313	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CAV1—atherosclerosis	9.43e-06	0.00031	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOA1—atherosclerosis	9.41e-06	0.000309	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CD36—atherosclerosis	9.32e-06	0.000307	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MTHFR—atherosclerosis	8.84e-06	0.00029	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HMOX1—atherosclerosis	8.73e-06	0.000287	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.69e-06	0.000286	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPARA—atherosclerosis	8.67e-06	0.000285	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LIPC—atherosclerosis	8.63e-06	0.000284	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CG—atherosclerosis	8.59e-06	0.000282	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOC3—atherosclerosis	8.58e-06	0.000282	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LDLR—atherosclerosis	8.53e-06	0.00028	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AGT—atherosclerosis	8.39e-06	0.000276	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOB—atherosclerosis	8.36e-06	0.000275	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CETP—atherosclerosis	8.33e-06	0.000274	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPARG—atherosclerosis	8.29e-06	0.000273	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOE—atherosclerosis	8.23e-06	0.00027	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CAV1—atherosclerosis	8.15e-06	0.000268	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTM1—atherosclerosis	8.14e-06	0.000267	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOA1—atherosclerosis	8.13e-06	0.000267	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—INS—atherosclerosis	8.13e-06	0.000267	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LPL—atherosclerosis	7.99e-06	0.000263	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.97e-06	0.000262	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GPX1—atherosclerosis	7.79e-06	0.000256	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CD36—atherosclerosis	7.59e-06	0.000249	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.53e-06	0.000248	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALB—atherosclerosis	7.45e-06	0.000245	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	7.42e-06	0.000244	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MTHFR—atherosclerosis	7.19e-06	0.000236	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPARG—atherosclerosis	7.16e-06	0.000236	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NOS3—atherosclerosis	7.13e-06	0.000234	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPARA—atherosclerosis	7.05e-06	0.000232	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—INS—atherosclerosis	7.03e-06	0.000231	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AGT—atherosclerosis	6.83e-06	0.000225	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.71e-06	0.000221	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOE—atherosclerosis	6.69e-06	0.00022	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CAV1—atherosclerosis	6.63e-06	0.000218	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOA1—atherosclerosis	6.62e-06	0.000218	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS2—atherosclerosis	6.52e-06	0.000214	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALB—atherosclerosis	6.44e-06	0.000212	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NOS3—atherosclerosis	6.16e-06	0.000203	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	6.04e-06	0.000199	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPARG—atherosclerosis	5.83e-06	0.000192	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.76e-06	0.000189	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—INS—atherosclerosis	5.72e-06	0.000188	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS2—atherosclerosis	5.64e-06	0.000185	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOB—atherosclerosis	5.52e-06	0.000181	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.37e-06	0.000176	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LPL—atherosclerosis	5.27e-06	0.000173	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALB—atherosclerosis	5.24e-06	0.000172	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GPX1—atherosclerosis	5.14e-06	0.000169	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NOS3—atherosclerosis	5.02e-06	0.000165	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CD36—atherosclerosis	5e-06	0.000165	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.74e-06	0.000156	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARA—atherosclerosis	4.65e-06	0.000153	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.59e-06	0.000151	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AGT—atherosclerosis	4.51e-06	0.000148	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOE—atherosclerosis	4.41e-06	0.000145	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CAV1—atherosclerosis	4.37e-06	0.000144	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOA1—atherosclerosis	4.36e-06	0.000143	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.98e-06	0.000131	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARG—atherosclerosis	3.85e-06	0.000126	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—INS—atherosclerosis	3.77e-06	0.000124	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALB—atherosclerosis	3.46e-06	0.000114	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NOS3—atherosclerosis	3.31e-06	0.000109	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKT1—atherosclerosis	3.28e-06	0.000108	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.03e-06	9.95e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKT1—atherosclerosis	2.83e-06	9.31e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKT1—atherosclerosis	2.31e-06	7.58e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.52e-06	5e-05	CbGpPWpGaD
